The Signal Note.
Our newsletter and archive of short notes on foreign-market questions worth bringing to the board.
Short notes for decisions that deserve evidence.
Each note frames one foreign-market question, the evidence that matters and the decision implication for the leadership team.
The UK-India FTA has a hidden readiness test
Tariff preference only protects margin if the origin claim survives the process.
Steel risk is now a stack, not a line item
Why the UK steel trade measure and incoming UK CBAM should be read as a cumulative margin-stack issue for downstream manufacturers.
Mexico is not a tariff shortcut
Why Mexico can still be a strong Americas base for UK manufacturers, but not as a simple route around US trade friction.
AI Act readiness is a market-access decision
How UK industrial and technology suppliers should decide where EU AI Act compliance investment protects revenue, and where it can wait.
A trade deal is not a trade corridor
A scorecard view of why UK exporters should evaluate trade agreements by corridor performance rather than signature value.
The route is now part of the market
Why the Red Sea disruption should change how boards compare overseas markets, not just how logistics teams book shipments.
India’s incentives do not answer the entry question
Why UK manufacturers should read India’s manufacturing incentives through ownership advantage, location fit and internalisation risk before choosing a route.
DPP is a readiness test, not just a regulation
Why UK exporters should treat EU DPP preparation as a product-data maturity programme, not a last-minute labelling task.
The Gulf window is not closing evenly
How to distinguish funded demand from winnable opportunity across GCC Vision 2030 sectors before committing sales resource.
The US lane is no longer one lane
Why UK exporters need to model the exact US lane by product, material content, origin and customer contract, not rely on a headline tariff view.
Vietnam is not a China substitute
A China+1 decision needs to separate Vietnam as a sales market, assembly base and sourcing alternative before the board signs off.
Where your CBAM exposure actually lives
Why the commercial exposure from EU CBAM sits across suppliers, customer contracts, working capital and margin, not only in the compliance calendar.
Five board questions before CBAM becomes a margin problem
A cross-functional decision frame for leadership.
Market size is not market fit
A practical way to compare foreign markets without letting one impressive number control the result.
When the right answer is not to enter
The strategic value of a well-evidenced Set Aside decision.
Start a conversation.
Bring us a market question the leadership team cannot yet answer. We will tell you whether it fits a defined product, what evidence it needs, and what the fixed fee would be. If it does not fit, we will say so.